Nationwide Fund Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

Nationwide Fund Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-17,611	Closed	-$151K	–	3472
2015 Q1	$151K	Sell	17,611 -565	-3%	-$5.05K	﹤0.01%	2830
2014 Q4	$181K	Buy	18,176 +191	+1%	+$1.63K	﹤0.01%	2683
2014 Q3	$178K	Buy	17,985 +141	+0.8%	+$2.09K	﹤0.01%	2756
2014 Q2	$309K	Buy	17,844 +163	+0.9%	+$2.66K	﹤0.01%	2523
2014 Q1	$314K	Hold	17,681	–	–	﹤0.01%	2283
2013 Q4	$324K	Sell	17,681 -583	-3%	-$11K	﹤0.01%	2448
2013 Q3	$489K	Buy	18,264 +4,112	+29%	+$88.1K	﹤0.01%	2232
2013 Q2	$261K	Buy	+14,152	New	+$250K	﹤0.01%	2365

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCM

Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return

Nationwide Fund Advisors's RPRX Position: Q2 2015 in Review

Nationwide Fund Advisors sold out of Repros Therapeutics Inc. (RPRX) in Q2 2015, closing a stake of 17,611 shares — an estimated $151K sold.

Nationwide Fund Advisors first reported a position in RPRX in Q2 2013 and held it in 8 quarters. The position peaked at $489K in Q3 2013. 64 funds tracked by Wall St. Rank hold RPRX as of Q2 2015.

Nationwide Fund Advisors reported no remaining Repros Therapeutics Inc. position as of Q2 2015 after selling out during the quarter.
Nationwide Fund Advisors sold 17,611 Repros Therapeutics Inc. shares in Q2 2015, an estimated $151K.
Nationwide Fund Advisors first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 8 quarters.
Nationwide Fund Advisors's Repros Therapeutics Inc. position peaked at $489K in Q3 2013.
64 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2015.

Based on Nationwide Fund Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.